Inverse Propensity Score-Weighted Analysis of Entecavir and Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B: A Large-Scale Multicenter Study

SIMPLE SUMMARY: It is still controversial whether tenofovir disoproxil fumarate (TDF) has a lower risk of hepatocellular carcinoma (HCC) development than entecavir (ETV) in patients with chronic hepatitis B (CHB). Furthermore, other antiviral treatment-related outcomes need to be evaluated between t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jihye, Hur, Moon Haeng, Kim, Seung Up, Kim, Jin-Wook, Sinn, Dong Hyun, Lee, Hyun Woong, Kim, Moon Young, Cheong, Jae Youn, Jung, Yong Jin, Lee, Han Ah, Jin, Young-Joo, Yoon, Jun Sik, Park, Sung-Jae, Lee, Chang Hun, Kim, In Hee, Lee, June Sung, Cho, Young Youn, Kim, Hyung Joon, Park, Soo Young, Seo, Yeon Seok, Oh, Hyunwoo, Jun, Dae Won, Kim, Mi Na, Chang, Young, Jang, Jae Young, Hwang, Sang Youn, Kim, Yoon Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252077/
https://www.ncbi.nlm.nih.gov/pubmed/37296898
http://dx.doi.org/10.3390/cancers15112936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252077/
https://www.ncbi.nlm.nih.gov/pubmed/37296898
http://dx.doi.org/10.3390/cancers15112936

Ejemplares similares